ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Tatva Chintan Pharma Chem Ltd

NSE: TATVA · BSE: 543321 · Chemicals & Petrochemicals · 32 announcements

Tatva Chintan Pharma Chem Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,655.00
Market cap: ₹3,871 Cr
Revenue (annual): ₹505.9 Cr
Net profit (annual): ₹42.05 Cr
P/E (TTM): 61.5×Sector 35.5×
Promoter holding: 72.02%+0.00% QoQ
FII holding: 4.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Other Announcement 4 Financial Results 4 Board Meeting Date 3 Annual General Meeting 3 Management Change 2 Debt & Borrowing 2 Capacity Expansion 2 Dividend 1 Credit Rating 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

32 announcements with these filters

13 Apr 2026 13:27 IST BSE

Financial Results

Tatva Chintan Pharma Chem Q3 FY26 Results: Net Profit ₹15.2 Cr, Up 15100.0% YoY

Tatva Chintan Pharma Chem Ltd reported net profit of ₹15.2 Cr (+15100.0% YoY) for Q3 FY26.

Key figure: Net profit ₹15.2 Cr · +15100.0% YoY

Open full results → Read the filing ↗

6 Apr 2026 16:34 IST BSE

Other Announcement

Tatva Chintan Pharma Chem Other Announcement

Tatva Chintan Pharma Chem Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate from MUFG Intime India confirms that security certificates received for dematerialisation were processed and cancelled within prescribed timelines.

Open announcement → Read the filing ↗

Tatva Chintan Pharma Chem Ltd by type